Financials in USD. Standardized financial statements.
A compact view of how Ascentage Pharma Group International turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $980.65M | $221.98M | $209.71M | $27.91M | $12.45M | $14.51M | $6.81M | $6.33M | $7.67M |
| Revenue Growth? | +341.8% | +5.9% | +651.4% | +124.2% | -14.2% | +113.2% | +7.6% | -17.5% | 0.0% |
| Cost of Revenue? | $29.09M | $30.54M | $22.00M | $3.33M | $1.97M | $2.10M | $0 | $0 | $261,000 |
| Gross Profit? | $951.57M | $191.44M | $187.71M | $24.58M | $10.48M | $12.42M | $6.81M | $6.33M | $7.41M |
| Gross Margin? | +97.0% | +86.2% | +89.5% | +88.1% | +84.2% | +85.6% | +100.0% | +100.0% | +96.6% |
| Operating Expenses? | $1.32B | $1.06B | $1.04B | $894.42M | $674.42M | $595.10M | $330.65M | $137.00M | $122.03M |
| Operating Income? | -$369.73M | -$872.64M | -$849.81M | -$869.84M | -$663.94M | -$582.68M | -$332.48M | -$130.67M | -$114.62M |
| EBITDA? | -$237.63M | -$743.61M | -$835.99M | -$915.99M | -$667.46M | -$596.26M | -$318.43M | -$49.68M | -$116.23M |
| Income Before Tax | -$395.25M | -$932.86M | -$887.17M | -$832.25M | -$675.45M | -$1.48B | -$346.91M | -$120.12M | -$107.84M |
| Income Tax Expense | $10.43M | -$7.15M | -$4.25M | -$49.83M | $2.16M | -$1.60M | -$1.60M | -$1.60M | $0 |
| Net Income? | -$405.43M | -$925.64M | -$882.92M | -$782.42M | -$677.61M | -$1.48B | -$345.31M | -$118.51M | -$107.84M |
| EPS? | $-1.34 | $-13.12 | $-13.40 | $-12.28 | $-12.56 | $-28.01 | $-6.67 | $-2.29 | $-2.08 |
| Diluted EPS? | $-1.34 | $-13.12 | $-13.40 | $-12.28 | $-12.56 | $-28.01 | $-6.67 | $-2.29 | $-2.08 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality